<http://webisa.webdatacommons.org/prov/227391893>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/12577361> .
<http://webisa.webdatacommons.org/12577361>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<globenewswire.com> .
<http://webisa.webdatacommons.org/12577361>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/25185589>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/12577361> .
<http://webisa.webdatacommons.org/12577361>	<http://www.w3.org/ns/prov#value>	"Alprolix was recently approved by Health Canada for the treatment of haemophilia B and is currently under review by regulatory authorities in several other countries including Australia and Japan." .